Test Price
2,800 AED✅ Home Collection Available
ATRX Gene Alpha-Thalassemia/Mental Retardation Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ATRX لمتلازمة ألفا ثلاسيميا/الإعاقة الذهنية في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
✅ 99.9% Diagnostic Sensitivity – ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
✅ Premium Logistics: Hospital-Grade Home Collection via ISO-Certified Cold-Chain & VIP Mobile Phlebotomy (8 AM–11 PM).
✅ Clinical Guidance: Complimentary Telephonic Post-Test Interpretation with a Genetic Counselor.
✅ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: يغطي اختبار تسلسل الجيل التالي لجين ATRX تشخيص متلازمة ألفا ثلاسيميا/الإعاقة الذهنية بدقة 99.9% عبر مختبراتنا المعتمدة من هيئة الصحة بدبي. نقدم خدمة سحب الدم المنزلي الفاخرة مع سلسلة تبريد معتمدة ISO، ودعم استشاري ما بعد الفحص. الالتزام بقانون الخدمات الصحية الاتحادي رقم 41 لسنة 2024 وخصوصية بيانات المرضى.
Clinical Overview of the ATRX Gene Test
This NGS-based test comprehensively sequences the ATRX gene to identify pathogenic variants linked to Alpha-Thalassemia/Mental Retardation Syndrome (ATR-X), a rare X-linked disorder presenting with severe intellectual disability, characteristic facial dysmorphism, and hemoglobin H disease. يُعد تحليل جين ATRX بتقنية التسلسل الجيني الشامل ضرورياً لتأكيد التشخيص الجيني، وتوجيه الإدارة السريرية متعددة التخصصات.
| Feature | Our Test (NGS Full Gene Sequencing) | Alternative: Single-site PCR / MLPA |
|---|---|---|
| Methodology | NGS (Illumina) with copy number variant (CNV) analysis | Targeted PCR for known mutations |
| Diagnostic Yield | >99% for point mutations and exon-level CNVs | 50–70% depending on variant spectrum |
| Turnaround Time | 3–4 Weeks | 2–4 Weeks |
| Coverage | All coding exons ± 20bp flanking introns | Limited to targeted region |
Physician Insight & Safety Protocol
"As a clinician, I emphasize that a positive ATRX result must be correlated with the patient’s full phenotype and family history. Genetic counseling is non-negotiable to interpret variant pathogenicity and guide surveillance for hematologic and neurodevelopmental complications." – Dr. PRABHAKAR REDDY, DHA License No. 61713011.
⚠️ Critical Medication Warning: Do not discontinue any prescribed medication or alter treatment without consulting your treating physician. This genetic test is for diagnostic and prognostic purposes and does not replace ongoing medical management.
Exclusion Criteria & Emergency Red Flags
- Patients with acute hemolytic crisis or severe anemia requiring immediate transfusion – stabilize first.
- Unwitnessed home collection in minors without legal guardian consent (per CDS Law 2026).
- Individuals currently on high-dose anticoagulants: coordinate with the phlebotomy team to schedule collection safely.
- Report immediately to ER if experiencing sudden confusion, respiratory distress, or unexplained bruising/bleeding before or after sample collection.
Primary Clinical Specialists for ATRX Testing
Neurologist
Clinical Intent: Evaluation of intellectual disability, neurodevelopmental regression, and seizure management in ATR-X syndrome. Guides MRI surveillance and early intervention strategies.
Hematologist
Clinical Intent: Diagnosis of alpha-thalassemia (HbH disease), monitoring for anemia, and coordination of transfusion or chelation therapy. Detects myelodysplasia risk.
Clinical Geneticist
Clinical Intent: Confirmatory sequencing, variant interpretation, family cascade testing, and reproductive counseling. Ensures alignment with DHA genetic testing guidelines.
Frequently Asked Questions (FAQ)
What is the purpose of the ATRX gene NGS test, and how does it guide treatment?
This test sequences the entire ATRX gene to identify disease-causing mutations, allowing clinicians to confirm a diagnosis of ATR-X syndrome, initiate targeted surveillance for hematologic and neurological complications, and provide accurate genetic counseling for the family. يقوم هذا الفحص بتحديد الطفرات المسببة للمرض في جين ATRX، مما يؤكد تشخيص متلازمة ألفا ثلاسيميا/الإعاقة الذهنية ويوجه خطة الرعاية متعددة التخصصات.
How long does it take to receive my ATRX genetic test result, and what does the report include?
Results are typically ready within 3–4 weeks. The comprehensive clinical report includes variant classification (pathogenic/likely pathogenic), zygosity, 2026 ICD-10 codes, and evidence-based recommendations for follow-up with a neurologist and hematologist. تظهر النتائج خلال 3 إلى 4 أسابيع، ويتضمن التقرير تصنيف الطفرة وتوصيات المتابعة مع الأطباء المتخصصين.
Is home blood collection available in Dubai and Abu Dhabi, and is it included in the 2800 AED fee?
Yes, our VIP mobile phlebotomy service covers all UAE emirates, including Dubai and Abu Dhabi, from 8 AM to 11 PM daily. The price includes certified cold-chain transport; insurance may be directly verified via WhatsApp. نعم، تتوفر خدمة سحب الدم المنزلي في جميع الإمارات، ويشمل السعر 2800 درهماً النقل المبرد المعتمد وإمكانية التحقق من التأمين مباشرة.
Compliance: Federal Decree-Law No. 41 of 2024 (Article 87), UAE PDPL (Data Privacy), CDS Law 2026 (Minors consent). Laboratory License: 9834453. ISO 9001:2015 Cert: INT/EGQ/2509DA/3139. ICD-10: D56.0, Q87.8, Z13.7. LOINC: 81663-8 (https://loinc.org/81663-8/).
Pre- requirement: A genetic counseling session to draw a pedigree chart and review family history is mandatory. For appointment: WhatsApp +971545488731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians